Found: 9
Select item for more details and to access through your institution.
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
Atypical Chronic Myeloid Leukemia: Where Are We Now?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6862, doi. 10.3390/ijms21186862
- By:
- Publication type:
- Article
Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S11, doi. 10.1016/j.clml.2017.09.039
- By:
- Publication type:
- Article
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 1016, doi. 10.1111/bjh.18352
- By:
- Publication type:
- Article
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 108, doi. 10.1111/bjh.17718
- By:
- Publication type:
- Article
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 853, doi. 10.1111/bjh.16434
- By:
- Publication type:
- Article
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.777730
- By:
- Publication type:
- Article
Precision Medicine Management of Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 642, doi. 10.3390/cancers12030642
- By:
- Publication type:
- Article